Organon & Co. Price Today
Organon & Co.
OGN
Healthcare
$5.49B
💰
Market Cap
7.3
💸
Price to Earnings
$3.0
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
6 |
Strong Buy |
1 |
Hold |
5 |
Sell |
1 |
Strong Sell |
0 |
OGN Price Forecast Target
21.5 👉 43.0 +100%
OGN EPS Forecast
3.0 👉 4.6 +56%
Financials
Profit Margin
12 %
Revenue Growth
-1.9 %
Dividend
$ 1.12
Held Percent
0.1% - Insiders
79.8% - Institutions
20.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $745.0M
-
💰 Blackrock Inc. $381.7M
-
💰 Mawer Investment Management Ltd. $312.2M
-
💰 State Street Corporation $301.8M
-
💰 Massachusetts Financial Services Co. $196.7M
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…📮FAQ
Some Frequently Asked Questions.
The Organon & Co. industry is Drug Manufacturers—General
The Organon & Co. sector is Healthcare
The Organon & Co. forecasted predicted Price to Earnings PE ratio is 4.7
The Organon & Co. Price to Earnings PE ratio is 7.3
The Market Capitalization of Organon & Co. is $5.49B
There are total of 254689357 float shares with 79.8% held by Institutions and 0.1% held by insiders
The MOrganon & Co. forecasted Earnings per Share EPS is $4.6
The Organon & Co. Earnings per Share EPS is 3.0
The Organon & Co. company has $3889000000 gross profits with 12 profit margins
The Organon & Co. Earnings Growth is -0.493% with -0.491% quarterly earnings growth
The Organon & Co. Revenue is $6144999936 with -0.019 revenue growth
The price target for Organon & Co. stock is $43.0 for the high target and $23.0 for the low target
The consensus analyst recommendations for Organon & Co. is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Organon & Co. is Hold, with the following breakdown:
- Buy: 6
- Strong Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
The Beta of Organon & Co. is 0.8
The dividend of Organon & Co. is $1.12
The dividend yield of Organon & Co. is 0.051999997%
The biggest institutional and mutual fund holders of Organon & Co. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Mawer Investment Management Ltd.
- State Street Corporation
The Organon & Co. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0